Table 2.
Sample Size and Study Duration Estimates for a Clinical Trial Using Severe Hypoglycemia as the Primary Outcomea
| SH rate in control groupb | Length of follow-up | SH relative reduction by interventionc | ||
|---|---|---|---|---|
| 50% | 25% | 10% | ||
| 5 | 1 month | 31,300 | 145,000 | 968,000 |
| 3 months | 10,400 | 48,200 | 323,000 | |
| 6 months | 5220 | 24,100 | 161,000 | |
| 15 | 1 month | 10,400 | 48,200 | 323,000 |
| 3 months | 3480 | 16,100 | 108,000 | |
| 6 months | 1740 | 8030 | 53,800 | |
| 30 | 1 month | 5220 | 24,100 | 161,000 |
| 3 months | 1740 | 8030 | 53,800 | |
| 6 months | 870 | 4010 | 26,900 | |
| 45 | 1 month | 3480 | 16,100 | 108,000 |
| 3 months | 1160 | 5350 | 35,900 | |
| 6 months | 580 | 2680 | 17,900 | |
Total number of subjects. Half would be randomized to each group. Assumes 90% power with type 1 error rate of 5% (two-tailed) and 1:1 allocation to intervention and control. This model likely underestimates the true sample size necessary because it assumes that every subject has the same Poisson rate whereas the true distribution is likely a mixture of Poisson outcomes.
Nocturnal events per 100 person-years.
For example, a 25% reduction when the SH rate is 30 in the control group would result in a rate of 22.5 in the intervention group.